Pomc knockout mice have secondary hyperaldosteronism despite an absence of adrenocorticotropin

Endocrinology

Volumn 149, Issue 2, 2008, Pages 681-686

  Linhart, Kirsten Berit ^a   Majzoub, Joseph A ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN II; CORTICOTROPIN; DEXAMETHASONE; ELECTROLYTE; GLUCOCORTICOID; PROOPIOMELANOCORTIN; RENIN; TETRACOSACTIDE;

ADRENAL INSUFFICIENCY; ALDOSTERONE BLOOD LEVEL; ALDOSTERONE RELEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ELECTROLYTE BLOOD LEVEL; ELECTROLYTE URINE LEVEL; HYPERALDOSTERONISM; HYPOALDOSTERONISM; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; SECONDARY HYPERALDOSTERONISM;

ADRENAL INSUFFICIENCY; ADRENOCORTICOTROPIC HORMONE; ALDOSTERONE; ANGIOTENSIN II; ANIMALS; FEMALE; HYPERALDOSTERONISM; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; POTASSIUM; PRO-OPIOMELANOCORTIN; RENIN; SODIUM; VASOCONSTRICTOR AGENTS;

EID: 38549151368     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2006-1136     Document Type: Article

References (32)

1. Hajnoczky G, Csordas G, Bago A, Chiu AT, Spat A 1992 Angiotensin II exerts its effect on aldosterone production and potassium permeability through receptor subtype AT1 in rat adrenal glomerulosa cells. Biochem Pharmacol 43:1009-1012
2. Ardaillou R 1999 Angiotensin II receptors. J Am Soc Nephrol 10(Suppl 11):S30-S39
3. de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T 2000 International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 52:415-472
4. Pedersen RC, Brownie AC 1980 Adrenocortical response to corticotropin is potentiated by part of the amino-terminal region of pro-corticotropin/endorphin. Proc Natl Acad Sci USA 77:2239-2243
5. Yoshida A, Nishikawa T, Tamura Y, Yoshida S 1991 ACTH-induced inhibition of the action of angiotensin II in bovine zona glomerulosa cells. A modulatory effect of cyclic AMP on the angiotensin II receptor. J Biol Chem 266:4288-4294
6. 2+ signal generation in rat adrenal glomerulosa cells. Biochem J 273(Pt 2):399-404
7. Aptel HB, Johnson EI, Vallotton MB, Rossier MF, Capponi AM 1996 Demonstration of an angiotensin II-induced negative feedback effect on aldosterone synthesis in isolated rat adrenal zona glomerulosa cells. Mol Cell Endocrinol 119:105-111
8. Luo X, Ikeda Y, Parker KL 1994 A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell 77:481-490
9. Gotoh H, Kusakabe M, Shiroishi T, Moriwaki K 1994 Survival of steroid 21-hydroxylase-deficient mice without endogenous corticosteroids after neonatal treatment and genetic rescue by transgenesis as a model system for treatment of congenital adrenal hyperplasia in humans. Endocrinology 135:1470-1476
10. Riepe FG, Tatzel S, Sippell WG, Pleiss J, Krone N 2005 Congenital adrenal hyperplasia: the molecular basis of 21-hydroxylase deficiency in H-2(aw18) mice. Endocrinology 146:2563-2574
11. + metabolism. Proc Natl Acad Sci USA 95:9424-9429
12. Bleich M, Warth R, Schmidt-Hieber M, Schulz-Baldes A, Hasselblatt P, Fisch D, Berger S, Kunzelmann K, Kriz W, Schutz G, Greger R 1999 Rescue of the mineralocorticoid receptor knock-out mouse. Pflugers Arch 438:245-254
13. Muglia L, Jacobson L, Dikkes P, Majzoub JA 1995 Corticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need. Nature 373:427-432
14. Yaswen L, Diehl N, Brennan MB, Hochgeschwender U 1999 Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nat Med 5:1066-1070
15. Karpac J, Ostwald D, Bui S, Hunnewell P, Shankar M, Hochgeschwender U 2005 Development, maintenance, and function of the adrenal gland in early postnatal pro-opiomelanocortin null mutant mice. Endocrinology 146:2555-2562
16. Coll AP, Challis BG, Yeo GS, Snell K, Piper SJ, Halsall D, Thresher RR, O'Rahilly S 2004 The effects of proopiomelanocortin deficiency on murine adrenal development and responsiveness to adrenocorticotropin. Endocrinology 145:4721-4727
17. Harding P, Sigmon DH, Alfie ME, Huang PL, Fishman MC, Beierwaltes WH, and Carretero OA 1997 Cyclooxygenase-2 mediates increased renal renin content induced by low-sodium diet. Hypertension 29:297-302
18. Kim SM, Chen L, Mizel D, Huang YG, Briggs JP, Schnermann J 2007 Low plasma renin and reduced renin secretory responses to acute stimuli in conscious COX-2-deficient mice. Am J Physiol Renal Physiol 292:F415-F422
19. Lantelme P, Rohrwasser A, Gociman B, Hillas E, Cheng T, Petty G, Thomas J, Xiao S, Ishigami T, Herrmann T, Terreros DA, Ward K, Lalouel JM 2002 Effects of dietary sodium and genetic background on angiotensinogen and renin in mouse. Hypertension 39:1007-1014
20. Muglia LJ, Jacobson L, Luedke C, Vogt SK, Schaefer ML, Dikkes P, Fukuda S, Sakai Y, Suda T, Majzoub JA 2000 Corticotropin-releasing hormone links pituitary adrenocorticotropin gene expression and release during adrenal insufficiency. J Clin Invest 105:1269-1277
21. Schimmer BP, Parker KL 1996 Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In: Hardman JG, Limbird LE, eds. Goodman and Gilman's the pharmacological basis of therapeutics. 9th ed. New York: McGraw Hill; 1459-1486
22. Tait SA, Tait JF, Coghlan JP 2004 The discovery, isolation and identification of aldosterone: reflections on emerging regulation and function. Mol Cell Endocrinol 217:1-21
23. Grossmann C, Scholz T, Rochel M, Bumke-Vogt C, Oelkers W, Pfeiffer AF, Diederich S, Bahr V 2004 Transactivation via the human glucocorticoid and mineralocorticoid receptor by therapeutically used steroids in CV-1 cells: a comparison of their glucocorticoid and mineralocorticoid properties. Eur J Endocrinol 151:397-406
24. Seifert C, Oelkers W 1981 Aldosterone response to sodium deprivation and angiotensin II in patients with hypopituitarism. Acta Endocrinol (Copenh) 96:361-369
25. Wallerath T, Witte K, Schafer SC, Schwarz PM, Prellwitz W, Wohlfart P, Kleinert H, Lehr HA, Lemmer B, Forstermann U 1999 Down-regulation of the expression of endothelial NO synthase is likely to contribute to glucocorticoid-mediated hypertension. Proc Natl Acad Sci USA 96:13357-13362
26. Bia MJ, Tyler K, DeFronzo R 1983 The effect of dexamethasone on renal potassium excretion and acute potassium tolerance. Endocrinology 113:1690-1696
27. Adam WR, Adams BA, Ellis AG 1987 In vivo estimation of changes in distal tubule flow and their role in dexamethasone-induced kaliuresis in control and potassium-adapted rats. Clin Exp Pharmacol Physiol 14:47-57
28. van Buren M, Rabelink TJ, Koppeschaar HP, Koomans HA 1993 Role of glucocorticoid in excretion of an acute potassium load in patients with Addison's disease and panhypopituitarism. Kidney Int 44:1130-1138
29. Lebrethon MC, Naville D, Begeot M, Saez JM 1994 Regulation of corticotropin receptor number and messenger RNA in cultured human adrenocortical cells by corticotropin and angiotensin II. J Clin Invest 93:1828-1833
30. Mountjoy KG, Bird IM, Rainey WE, Cone RD 1994 ACTH induces upregulation of ACTH receptor mRNA in mouse and human adrenocortical cell lines. Mol Cell Endocrinol 99:R17-R20
31. Williams GH, Rose LI, Dluhy RG, Dingman JF, Lauler DP 1971 Aldosterone response to sodium restriction and ACTH stimulation in panhypopituitarism. J Clin Endocrinol Metab 32:27-35
32. Dluhy RG, Himathongkam T, Greenfield M 1974 Rapid ACTH test with plasma aldosterone levels. Improved diagnostic discrimination. Ann Intern Med 80:693-696